Search Results - "Tarín‐Arzaga, L."
-
1
PB2347: GLOBAL REPRESENTATION AMONG JOURNAL EDITORS IN HEMATOLOGY: ARE WE DIVERSE, EQUITABLE, AND INCLUSIVE?
Published in HemaSphere (23-06-2022)Get full text
Journal Article -
2
Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience
Published in Hematology (Luxembourg) (01-06-2007)“…Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective strategy for preventing relapse of acute myelogenous leukemia (AML). We analyzed the…”
Get more information
Journal Article -
3
PB1982: DEEPENING OF RESPONSE IN PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: A MULTICENTRIC STUDY IN A LATINO POPULATION
Published in HemaSphere (23-06-2022)Get full text
Journal Article -
4
-
5
Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?
Published in Bone marrow transplantation (Basingstoke) (01-07-2008)“…A total of 72 patients with Ph-positive CML in first chronic phase were followed during a 6-year period in two different institutions in México. Among them, 22…”
Get full text
Journal Article -
6
Outpatient allografting using non-myeloablative conditioning: the Mexican experience
Published in Bone marrow transplantation (Basingstoke) (01-07-2007)“…A group of 132 patients with both malignant and nonmalignant conditions was allografted using the 'Mexican' method of non-ablative conditioning. The…”
Get full text
Journal Article -
7
Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experience
Published in Bone marrow transplantation (Basingstoke) (01-10-2005)“…We have analyzed the transfusion requirements of a group of 132 peripheral blood stem cell transplants from a single institution (73 allografts and 59…”
Get full text
Journal Article -
8
Impact of the affordability of novel agents in patients with multiple myeloma: Real‐world data of current clinical practice in Mexico
Published in Cancer (01-05-2018)“…BACKGROUND The treatment of multiple myeloma (MM) has become costly and difficult to access for patients living in low‐income to middle‐income countries…”
Get full text
Journal Article -
9
294: Alemtuzumab in the treatment of steroid refractory acute graft-versus-host disease
Published in Biology of blood and marrow transplantation (2007)Get full text
Journal Article -
10
Reduced-intensity stem cell transplantation in children and adolescents: The Mexican experience
Published in Biology of blood and marrow transplantation (01-03-2003)“…A group of 21 consecutive patients aged 4-20 (median 13) years was prospectively allografted using a reduced intensity preparative regimen. The group included…”
Get full text
Journal Article